Real body recomposition is rarely a single-pathway problem
Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant
Stickel F, Kessebohm K, Weimann R, Seitz HK
The appropriate injection angle depends on the needle size, body composition, and your providers instructions
Protective Measures Wear long sleeves and pants during activities that risk bumps, use padding for contact sports where appropriate, and arrange living spaces to reduce fall risks, remove rugs, improve lighting, and install handrails where needed
The Retatrutide pairing simply reaches for more by including that third receptor